Search Results 1351-1360 of 21195 for Informed consent

1. BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients with Advanced Solid Tumors, Phase I Studies with Expansion Cohorts in Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) and Pancreatic Adenocarcinoma (PDA) - Mayo Clinic

   Patient must have the ability to understand and the willingness to sign a written informed consent document. Participants with impaired decision-making ...

2. Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty - Mayo Clinic

   Cognitively intact with the ability to give informed consent as outlined by our institutional review board. Patients must be capable of participating in the ...

3. A Study to Evaluate Posoleucel ALVR105 to Treat Kidney Transplant Recipients with BK Viremia - Mayo Clinic

   Patients must be ≥18 years of age at the time of signing the informed consent. Patients who had a kidney transplant performed ≥ 28 days prior to ...

4. Research With I-124 EVuzamitide To Elucidate Cardiac AmyLoidosis - Mayo Clinic

   ... informed consent form (ICF) and in this protocol. * Male or female ≥18 years of age. * Is suspected of having cardiac amyloidosis and is undergoing or will ...

5. Dose-Escalation Study of cevostamab (BFCR4350A) in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) - Mayo Clinic

   Signed Informed Consent Form(s). Age ≥ 18 years at time of signing Informed Consent Form. Ability to comply with the study protocol, in the investigator's ...

6. Safety and Tolerability of GTX-104 Compared With Oral Nimodipine in Patients With aSAH - Mayo Clinic

   Hunt and Hess score from I to V just prior to randomization. 4. Subject or the subject's legal representative has signed informed consent (either in person ...

7. S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma - Mayo Clinic

   ... informed consent in accordance with institutional and federal guidelines; As a part of the Oncology Patient Enrollment Network (OPEN) registration process ...

8. A Study to Investigate the Effectiveness and Safety of Pf-04965842 in Subjects Aged 12 Years and Over, With Moderate to Severe Atopic Dermatitis with the Option of Rescue Treatment in Flaring Subjects - Mayo Clinic

   ... informed of all pertinent aspects of the study. Male or female subjects of 12 years of age or older, at the time of informed consent and body weight ≥ 40 kg.

9. A Study to Evaluate the Performance of a Diagnostic Test for Amyotrophic Lateral Sclerosis - Mayo Clinic

   ... informed consent and authorization to use protected health information (PHI) in accordance with national and local subject privacy regulations; Aged 21 to 80 ...

10. A Study to Compare Docetaxel/Prednisone to Docetaxel/Prednisone Combined with OGX-011 in Men with Prostate Cancer - Mayo Clinic

    Written informed consent must be obtained prior to any protocol-specific procedures being performed. Exclusion Criteria. Received any other cytotoxic ...